Brief: Dishman Carbogen Amcis Says Subsidiary Awarded Drug Manufacturing License From Chinese NMPA
21/04/2025 15:22
April 21 (Reuters) - Dishman Carbogen Amcis Ltd DSHM.NS: SUBSIDIARY AWARDED DRUG MANUFACTURING LICENSE FROM CHINESE NMPA Source text: ID:nBSEbg8Dhs Further company coverage: DSHM.NS ((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Dishman Carbogen Amcis
See all newsBrief: Dishman Carbogen Amcis Approves Raising Of Funds Via NCDs Worth Up To 380 Million Rupees
India's Dishman Carbogen Amcis falls after posting quarterly loss
Brief: Dishman Carbogen Amcis June-Quarter Consol Net Loss 578.8 Million Rupees
Brief: Dishman Carbogen Amcis Says Unit Successfully Completed GMP Inspection By China's NMPA For Shanghai Site
Brief: Dishman Carbogen Amcis Ltd Approves Issue Of Up To 1 Billion Rupees NCDs On Private Placement Basis